Rational Drug Design of DNA Oligonucleotides as HIV Inhibitors
Current Drug Target -Infectious Disorders · 2001
DOI: 10.2174/1568005013343173 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Current Drug Target -Infectious Disorders, 2001. Verfasst von N Jing und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. njing@bcm.tmc.edu. Hauptthemen laut MEDLINE: Drug Design. Die Arbeit wurde bisher 10-mal zitiert (Crossref). Gefördert von: NIGMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Infectious Diseases, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA. njing@bcm.tmc.edu
Förderung
- NIGMS NIH HHS
Zitieren
APA
Jing, N., & Xu, X. (2001). Rational Drug Design of DNA Oligonucleotides as HIV Inhibitors. Current Drug Target -Infectious Disorders. https://doi.org/10.2174/1568005013343173
Vancouver
Jing N, Xu X. Rational Drug Design of DNA Oligonucleotides as HIV Inhibitors. Current Drug Target -Infectious Disorders. 2001. doi:10.2174/1568005013343173
BibTeX
@article{Jing2001,
author = {Jing, N and Xu, X},
title = {Rational Drug Design of DNA Oligonucleotides as HIV Inhibitors},
journal = {Current Drug Target -Infectious Disorders},
year = {2001},
doi = {10.2174/1568005013343173}
}
EUVIMED